Pepscan (Antisoma)

N/A

Report date: 2025/11/24 11:49:03

Base Information

Drug NamePepscan (Antisoma)

Drug Alias NameAS-109

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsDiagnostic agent (In vivo) > Radionuclide Imaging agent +[7]

Mechanisms of ActionRadionuclide imaging enhancers

TargetsMucin-1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAntisoma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAntisoma

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A